Clinical Trial Update: A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma [Phase 1]

View source ↗

Summary

The trial, a Phase Ib study of belinostat with RDHAP chemotherapy for relapsed or refractory diffuse large B-cell lymphoma, has been withdrawn. No study results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• BELEODAQ (BELINOSTAT)
• CYTARABINE (CYTARABINE)
• Decadron (Dexamethasone)
• Platinol (cisplatin)
• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1 | Status: WITHDRAWN